Form 144 Filed for CCB — 1,708 Shares from RSUs Planned Sale
Rhea-AI Filing Summary
Form 144 filed for ticker CCB discloses a proposed sale of 1,708 shares of common stock through Stifel Nicolaus & Company, with an aggregate market value of $186,350. The shares represent a small fraction of the reported 15,109,090 shares outstanding. The securities were acquired as restricted stock units on 05/28/2025 and paid in cash on the same date. The approximate date of sale is listed as 09/15/2025. The filing does not identify the specific issuer name or the individual for whose account the sale is to be made; that information is absent from the provided form content.
Positive
- Clear transaction details including broker, acquisition date, RSU nature, and planned sale date are disclosed
- Relatively small size (1,708 shares) representing approximately 0.011% of reported shares outstanding, implying limited market impact
Negative
- Issuer name and selling person's identity are not provided in the supplied content, reducing transparency
- Sale involves recently vested RSUs, which could be viewed as insider liquidity rather than long-term commitment
Insights
TL;DR: Small insider sale of recently vested RSUs; immaterial to capital structure but worth noting for insider activity tracking.
The filing documents an intent to sell 1,708 shares valued at $186,350 via a broker on 09/15/2025. The shares were granted and settled as restricted stock units on 05/28/2025. Relative to the reported 15,109,090 shares outstanding, the amount represents roughly 0.011% of outstanding shares, which is immaterial from a dilution or market-cap perspective. The lack of a named issuer and the unnamed selling person in the provided content limits attribution and context for evaluating motives or timing.
TL;DR: Proper Rule 144 disclosure filed, but missing issuer/person details reduce transparency for investors.
The form shows compliance with Rule 144 mechanics: acquisition date, nature (RSUs), broker details, and intended sale date are provided. However, the provided extract omits the issuer's name and the identity/relationship of the seller, which are material for governance oversight and insider-transaction monitoring. That omission prevents a full assessment of potential conflicts or insider signaling.